ANI PHARMACEUTICALS, INC Increase (Decrease) in Accounts Payable, Trade
ANI PHARMACEUTICALS, INC (ANIP) reported Increase (Decrease) in Accounts Payable, Trade of $2.13 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2019-11-06
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts payable, trade for the quarter ending 2019-09-30 was $798.00K.
- ANI PHARMACEUTICALS, INC increase (decrease) in accounts payable, trade for the quarter ending 2018-09-30 was -$2.32M.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month |
|---|---|---|---|
| 2019-09-30 | $798.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $2.13M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.33M 10-Q · filed 2019-08-07 | ||
| 2018-09-30 | -$2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $2.25M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $4.57M 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |